Strength
2 mg/1
Manufacturer
AvPAKNDC
50268012815
Classification
Generic
Dosage Form
TABLET
Route
SUBLINGUAL
Last Updated
6/17/2026
Active Ingredients
BUPRENORPHINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA201760On Market Since
3/19/2024
Pharmacological Classes
Price Statistics
The NADAC for BUPRENORPHINE 2 MG TABLET SL has been published 98 times since Aug 14, 2024, and over the history we have for it it has declined 40.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2629 per EA |
|---|---|
| All-time high | $0.6289 (Sep 11, 2024) |
| All-time low | $0.2629 (Jun 17, 2026) |
| 52-week high | $0.3346 |
| 52-week low | $0.2629 |
| Median price | $0.3257 |
| Average price | $0.3484 |
| Largest weekly change | +42.0% (Aug 21, 2024) |
| Weeks tracked | 98 |
| Tracking since | Aug 14, 2024 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUPRENORPHINE 2 MG TABLET SL?
The current National Average Drug Acquisition Cost (NADAC) for BUPRENORPHINE 2 MG TABLET SL, manufactured by AvPAK, is $0.2629 per EA (NDC 50268012815), effective Jun 24, 2026.
How has the price of BUPRENORPHINE 2 MG TABLET SL changed over time?
Over the history we have for it, the NADAC for BUPRENORPHINE 2 MG TABLET SL has declined 40.6%. It has been tracked across 98 weekly CMS publications since Aug 14, 2024.
What are the highest and lowest recorded NADAC prices for BUPRENORPHINE 2 MG TABLET SL?
Since Aug 14, 2024, the NADAC for BUPRENORPHINE 2 MG TABLET SL has ranged from a low of $0.2629 (Jun 17, 2026) to a high of $0.6289 (Sep 11, 2024), with a median of $0.3257 per EA.
Are there cheaper alternatives to BUPRENORPHINE 2 MG TABLET SL?
5 NADAC-published products share the same active ingredient, strength, and dosage form as BUPRENORPHINE 2 MG TABLET SL, but none are currently priced below it.
Who manufactures BUPRENORPHINE 2 MG TABLET SL?
BUPRENORPHINE 2 MG TABLET SL (NDC 50268012815) is labeled by AvPAK, and CMS classifies it as a generic product.
Related Drugs
Same classification